Advertisement

Post-therapy Marrow Changes

  • Jason H. KurzerEmail author
  • Olga K. Weinberg
Chapter
Part of the Atlas of Anatomic Pathology book series (AAP)

Abstract

Bone marrow biopsies and aspirates from patients undergoing various forms of treatment can show a variety of histological and cytological findings, and it is therefore imperative that pathologists understand the array of associated therapy-related effects. Patients receiving induction chemotherapy for acute leukemia frequently have bone marrow aspirates and/or biopsies at specific intervals, allowing the pathologist to observe the immediate and long-term effects of the treatment regimen (Table 3.1).

Keywords

Myeloablative therapy Growth factor therapy Post-ATRA findings Tyrosine kinase inhibitor Rituximab 

References

  1. 1.
    Islam A, Catovsky D, Galton DAG. Histological study of bone marrow regeneration following chemotherapy for acute myeloid leukemia and chronic granulocytic leukemia in blast transformation. Br J Haematol. 1980;45:535–40.CrossRefPubMedGoogle Scholar
  2. 2.
    Dick FR, Burns CP, Weiner GJ, Heckman KD. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML). Hematol Pathol. 1995;9:95–106.PubMedGoogle Scholar
  3. 3.
    Kushwaha R, Kumar A, Aggrawal K, Nigam N, Kumar A. Post chemotherapy blood and bone marrow regenerative changes in childhood acute lymphoblastic leukemia: a prospective study. Indian J Pathol Microbiol. 2014;57:72–7.  https://doi.org/10.4103/0377–4929.130903.CrossRefPubMedGoogle Scholar
  4. 4.
    Campbell LJ, Maher DW, Tay DL, Boyd AW, Rockman S, McGrath K, et al. Marrow proliferation and the appearance of giant neutrophils in response to recombinant human granulocyte colony stimulating factor (rhG-CSF). Br J Haematol. 1992;80:298–304.CrossRefPubMedGoogle Scholar
  5. 5.
    Ryder JW, Lazarus HM, Farhi DC. Bone marrow and blood findings after marrow transplantation and rhGM-CSF therapy. Am J Clin Pathol. 1992;97:631–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Schmitz LL, McClure JS, litz CE, Dayton V, Weisdorf DJ, Parkin JL, Brunning RD. Morphologic and quantitative changes in blood and marrow cells following growth factor therapy. Am J Clin Pathol. 1994;101:67–75.CrossRefPubMedGoogle Scholar
  7. 7.
    Harris AC, Todd WM, Hackney MH, Ben-Ezra J. Bone marrow changes associated with recombinant granulocyte-macrophage and granulocyte colony-stimulating factors: discrimination of granulocytic regeneration. Arch Pathol Lab Med. 1994;118:624–9.PubMedGoogle Scholar
  8. 8.
    Raynaud P, Caulet-Maugendre S, Foussard C, Salles G, Moreau A, Rossi JF, et al. GOELAMS Group. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy? Hum Pathol. 2008;39:194–200.CrossRefPubMedGoogle Scholar
  9. 9.
    Miyauchi J, Ohyashiki K, Inatomi Y, Toyama K. Neutrophil secondary-granule deficiency as a hallmark of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood. 1997;90:803–13.PubMedGoogle Scholar
  10. 10.
    Hasserjian RP, Boecklin F, Parker S, Chase A, Dhar S, Zaiac M, et al. ST1571 (imatinib mesylate) reduces bone marrow cellularity and normalizes morphologic features irrespective of cytogenetic response. Am J Clin Pathol. 2002;117:360–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Frater JL, Tallman MS, Variakojis D, Druker BJ, Resta D, Riley MB, et al. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status. Am J Clin Pathol. 2003;119:833–41.CrossRefPubMedGoogle Scholar
  12. 12.
    McNamara C, Grigg A, Szer J, Roberts A, Campbell L, Hoyt R, et al. Morphological effects of imatinib mesylate (STI571) on the bone marrow and blood of patients with Philadelphia chromosome (Ph) positive chronic myeloid leukaemia. Clin Lab Haematol. 2003;25:119–25.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2018

Authors and Affiliations

  1. 1.Stanford University School of MedicineStanfordUSA
  2. 2.Pathology DepartmentBoston Children’s HospitalBostonUSA

Personalised recommendations